Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis

Changes is lymphocyte subpopulations in peripheral blood have been proposed as biomarkers for evaluation of disease activity in multiple sclerosis (MS). Serum neurofilament light chain (sNfL) is a biomarker reflecting neuro-axonal injury in MS that could be used to monitor disease activity, response to drugs and to prognosticate disease course. Here we show a moderate correlation between sNfL and lymphocyte cell subpopulations, and our data furthermore suggest that sNfL and specific immune cell subpopulations together could predict future disease worsening in MS.

Source: Journal of Neuroimmunology - August 7, 2023 Category: Allergy & Immunology Authors: Synne Brune-Ingebretsen, Einar A. H øgestøl, Nicole Kerlero de Rosbo, Pål Berg-Hansen, Cathrine Brunborg, Kaj Blennow, Henrik Zetterberg, Friedemann Paul, Antonio Uccelli, Pablo Villoslada, Hanne F. Harbo, Tone Berge Source Type: research